Figure 2 presents HHLA2 immunostaining in CRC specimens, with staining of the glands and accompanying infiltration of lymphocytes. Table 2 presents the division of the examined tumors into HHLA2-positive and HHLA2-negative tumors. Here, HHLA2 is linked to colorectal carcinoma.